Cover Image
市場調查報告書

Addex Therapeutics : 產品平台分析

Addex Therapeutics Ltd - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 243037
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
Addex Therapeutics : 產品平台分析 Addex Therapeutics Ltd - Product Pipeline Review - 2016
出版日期: 2016年05月25日 內容資訊: 英文 57 Pages
簡介

Addex Therapeutics Ltd 是致力於開發針對神經病變的可口服藥用小分子變構調節因子的生物製藥公司。

本報告提供Addex Therapeutics Ltd的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Addex Therapeutics Ltd的基本資料

  • Addex Therapeutics Ltd概要
  • 主要資訊
  • 企業資料

Addex Therapeutics Ltd:R&D概要

  • 主要的治療範圍

Addex Therapeutics Ltd:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Addex Therapeutics Ltd:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅱ期的產品/聯合治療模式
    • 第Ⅰ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • IND/CTA 所申請的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Addex Therapeutics Ltd:藥物簡介

Addex Therapeutics Ltd:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Addex Therapeutics Ltd:最近的開發平台趨勢

Addex Therapeutics Ltd:暫停中的計劃

Addex Therapeutics Ltd:中止開發的開發中產品

  • 中止開發的開發中產品簡介
    • ADX-10059
    • ADX-10061
    • ADX-71943

Addex Therapeutics Ltd:企業發表

Addex Therapeutics Ltd:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08052CDB

Summary

Global Markets Direct's, 'Addex Therapeutics Ltd - Product Pipeline Review - 2016', provides an overview of the Addex Therapeutics Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Addex Therapeutics Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Addex Therapeutics Ltd
  • The report provides overview of Addex Therapeutics Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Addex Therapeutics Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Addex Therapeutics Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Addex Therapeutics Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Addex Therapeutics Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Addex Therapeutics Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Addex Therapeutics Ltd Snapshot
    • Addex Therapeutics Ltd Overview
    • Key Information
    • Key Facts
  • Addex Therapeutics Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Addex Therapeutics Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Addex Therapeutics Ltd - Pipeline Products Glance
    • Addex Therapeutics Ltd - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Addex Therapeutics Ltd - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Addex Therapeutics Ltd - Drug Profiles
    • dipraglurant IR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dipraglurant ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-71441
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-71743
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-88178
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-92639
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit FSHR/LHR For Sex Hormone Dependent Tumors
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize mGluR2 for Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize mGluR7 For Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-90125
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADX-95477
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize A2A for Immunology, Hematological and Neurological Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize FSH Receptor for Women's Health
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Agonize TRKB for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize TNFR1 for Immunology, Gastrointestinal, Neurology and Hematological Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Modulate mGlu3 Receptor for CNS Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Addex Therapeutics Ltd - Pipeline Analysis
    • Addex Therapeutics Ltd - Pipeline Products by Target
    • Addex Therapeutics Ltd - Pipeline Products by Route of Administration
    • Addex Therapeutics Ltd - Pipeline Products by Molecule Type
    • Addex Therapeutics Ltd - Pipeline Products by Mechanism of Action
  • Addex Therapeutics Ltd - Recent Pipeline Updates
  • Addex Therapeutics Ltd - Dormant Projects
  • Addex Therapeutics Ltd - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ADX-10059
      • ADX-10061
      • ADX-71943
  • Addex Therapeutics Ltd - Company Statement
  • Addex Therapeutics Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Addex Therapeutics Ltd, Key Information
  • Addex Therapeutics Ltd, Key Facts
  • Addex Therapeutics Ltd - Pipeline by Indication, 2016
  • Addex Therapeutics Ltd - Pipeline by Stage of Development, 2016
  • Addex Therapeutics Ltd - Monotherapy Products in Pipeline, 2016
  • Addex Therapeutics Ltd - Out-Licensed Products in Pipeline, 2016
  • Addex Therapeutics Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016
  • Addex Therapeutics Ltd - Phase II, 2016
  • Addex Therapeutics Ltd - Phase I, 2016
  • Addex Therapeutics Ltd - IND/CTA Filed, 2016
  • Addex Therapeutics Ltd - Preclinical, 2016
  • Addex Therapeutics Ltd - Discovery, 2016
  • Addex Therapeutics Ltd - Pipeline by Target, 2016
  • Addex Therapeutics Ltd - Pipeline by Route of Administration, 2016
  • Addex Therapeutics Ltd - Pipeline by Molecule Type, 2016
  • Addex Therapeutics Ltd - Pipeline Products by Mechanism of Action, 2016
  • Addex Therapeutics Ltd - Recent Pipeline Updates, 2016
  • Addex Therapeutics Ltd - Dormant Developmental Projects,2016
  • Addex Therapeutics Ltd - Discontinued Pipeline Products, 2016
  • Addex Therapeutics Ltd, Subsidiaries

List of Figures

  • Addex Therapeutics Ltd - Pipeline by Top 10 Indication, 2016
  • Addex Therapeutics Ltd - Pipeline by Stage of Development, 2016
  • Addex Therapeutics Ltd - Monotherapy Products in Pipeline, 2016
  • Addex Therapeutics Ltd - Out-Licensed Products in Pipeline, 2016
  • Addex Therapeutics Ltd - Pipeline by Top 10 Target, 2016
  • Addex Therapeutics Ltd - Pipeline by Route of Administration, 2016
  • Addex Therapeutics Ltd - Pipeline by Molecule Type, 2016
  • Addex Therapeutics Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top